Última revisão: 30 Out 2021
Última atualização: 23 Jun 2021

Resumo

Diagnósticos diferenciais

comuns

  • Cistite
  • Uretrite
  • Pielonefrite
  • Vulvovaginite (incluindo vaginose bacteriana)
  • Balanite
  • Prostatite aguda
  • Hiperplasia prostática benigna
  • Urolitíase
  • Irritantes locais

Incomuns

  • Vírus do herpes simples (HSV) genital
  • Epidídimo-orquite
  • Cervicite
  • Esquistossomose
  • Tuberculose
  • Estenose uretral
  • Intervenção ou cateterismo
  • Abuso sexual
  • Esportes
  • Cistite intersticial
  • Vaginite atrófica
  • Espondiloartropatias
  • Prostatite não infecciosa
  • Bexiga inflamada pela cetamina
  • Fístula urinária
  • Câncer de próstata
  • Câncer de bexiga
  • Câncer renal
  • Câncer cervical
  • Câncer uretral
  • Câncer peniano
  • Medicamentos ou fitoterápicos

Colaboradores

Autores

Kasra Saeb-Parsy, BSc, MBBS, AFHEA, FRCSEd (Urol)
Kasra Saeb-Parsy

Consultant Urologist

Cambridge University Hospitals NHS Foundation Trust

Cambridge

UK

Honorary Lecturer

Anglia Ruskin University

Cambridge

UK

Declarações

KS-P declares that he has no competing interests.

Elaine Lee, MBBS, MA, FRCS (Urol)

Functional Urology Fellow

Eastern Health

Melbourne

Australia

Declarações

EL declares that she has no competing interests.

Agradecimentos

Kasra Saeb-Parsy and Elaine Lee would like to acknowledge Dr Vincent J. Gnanapragasam, a previous contributor to this topic.

Declarações

VJG declares that he has no competing interests.

Revisores

Robert Pickard, MD, FRCS (Urol)

Professor of Urology

Institute of Cellular Medicine

Newcastle University

Newcastle upon Tyne

UK

Declarações

RP has received funding from the UK NHS (NIHR) to undertake commissioned reviews of treatment for benign prostatic enlargement.

George Martin, MD

Instructor

Department of Urology

Mayo Clinic

Scottsdale

AZ

Declarações

GM declares that he has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal